Advertisement

Topics

Rocket Pharmaceuticals, Ltd. Company Profile

05:00 EDT 19th June 2018 | BioPortfolio

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. Rocket’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. Rocket's lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. Preclinical studies of additional bone marrow-derived disorders are ongoing and target Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). Rocket is also developing an AAV-based gene therapy program for an undisclosed rare pediatric disease. For more information about Rocket, please visit www.rocketpharma.com.


News Articles [589 Associated News Articles listed on BioPortfolio]

Rocket Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced that Gaurav Shah, M.D., Chief Executive...

The Alt Rocket Tech That May One Day Take Humans to Mars

On Feb. 6, SpaceX made history when it launched its Falcon Heavy rocket from Cape Canaveral in Florida. It now reigns as the biggest and most powerful rocket in the world. Elon Musk, the messianic CEO...

Rocket Pharmaceuticals Announces Participation in a Fireside Chat at the Leerink Partners 7th Annual Global Healthcare Conference

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced that Gaurav Shah, M.D., Chief Executiv...

Rocket Pharmaceuticals to Present at the Cowen & Company 38th Annual Health Care Conference

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced that Gaurav Shah, M.D., Chief Executive...

Rocket Pharmaceuticals to Present at Upcoming Investor Conferences

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announced that Gaurav Shah, M.D., Chief Executive...

VIDEO: Pooled analysis of Rocket studies shows efficacy of Rhopressa

WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting, Robert Fechtner, MD, discusses the findings of a pooled analysis of more than 800 patients in the Rocket 1, 2 and 4 c...

Photos: SpaceX successfully launches new Falcon Heavy rocket carrying Tesla Roadster

The world’s newest and most powerful rocket had its maiden launch on Tuesday afternoon as SpaceX launched the Falcon Heavy rocket for the first time.

Rocket Pharmaceuticals posts $19.6 million annual net loss

Rocket Pharmaceuticals, which recently merged with Inotek Pharmaceuticals, reported a net loss of $19.6 million, or $219.49 per share, in 2017 compared with a net loss of $7.6 million, or $84.43 per s...

Drugs and Medications [272 Associated Drugs and Medications listed on BioPortfolio]

Iontophoresis [ROCKET ELECTRIC CO., LTD.]

Drug Facts

Xarelto [Janssen Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use XARELTO (rivaroxaban) safely and effectively. See full prescribing information for XARELTO. XARELTO (rivaroxaban) tablets, for oral u...

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

PubMed Articles [143 Associated PubMed Articles listed on BioPortfolio]

Effect of population density of lettuce intercropped with rocket on productivity and land-use efficiency.

The objective of this study was to evaluate the influence of the spacing of lettuce rows on the production of a lettuce-rocket intercropping system over two growing seasons (11 August to 25 September ...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Balanced design for the feasible super rocket fuels: A first-principle study on gauche CHN and CHN.

On the basis of the framework of cubic gauche nitrogen (cg-N), six one-eighth methanetriyl groups (>CH-) substitutes and fifteen one-fourth >CH- substitutes were optimized using the first-principle ...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Clinical Trials [223 Associated Clinical Trials listed on BioPortfolio]

Rocket® Pleural Catheters: QOL, Feasibility and Satisfaction in Recurrent MPE Patients

This study will take place in Ottawa, Ontario, and will include 100 patients who are receiving tunnelled pleural catheters to treat their symptoms of MPE. The aim of this study is to evalu...

Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis

Ascites (accumulation of fluid in the abdominal cavity) is a common problem which can lead to distressing symptoms. When caused by cancer, management options are chemotherapy, diuretics an...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Companies [1326 Associated Companies listed on BioPortfolio]

Rocket Pharmaceuticals, Ltd.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment o...

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) (“Rocket”) is an emerging, clinical-stage biotechnology company focused on developing first-in-class gene therapy treatment op...

Rocket Fuel

Rocket Fuel delivers a leading programmatic media-buying platform at Big Data scale that harnesses the power of artificial intelligence (AI) to improve marketing ROI in digital me...

Rocket Careers, Inc

Rocket Careers, Inc. is a direct hire service to San Francisco Bay Area biotech, pharmaceutical and medical device companies. We specialize in recruiting and placing experienced candidates in clinical...

Rocket Resources, Inc

RocketResume is a service of Rocket Resources, Inc, an Employment Information Services Company dedicated to providing job seekers the most comprehensive and up-to-date employment information availabl...

More Information about "Rocket Pharmaceuticals, Ltd." on BioPortfolio

We have published hundreds of Rocket Pharmaceuticals, Ltd. news stories on BioPortfolio along with dozens of Rocket Pharmaceuticals, Ltd. Clinical Trials and PubMed Articles about Rocket Pharmaceuticals, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rocket Pharmaceuticals, Ltd. Companies in our database. You can also find out about relevant Rocket Pharmaceuticals, Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record